REQUEST A DEMO
Total
USD $0.00
Search more companies

Elogio Asia Pacific Sdn. Bhd. (Malaysia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Elogio Asia Pacific Sdn. Bhd. Profile Updated: February 05, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Elogio Asia Pacific Sdn. Bhd. is based in Malaysia. The head office is in Subang Jaya. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. The company was established on July 11, 2008. The latest financial highlights indicate a net sales revenue increase of 85.34% in 2022. Its’ total assets recorded a growth of 109.73%. In 2022, Elogio Asia Pacific Sdn. Bhd.’s net profit margin decreased by 0.86%.

Headquarters
Ct-09-09, 9Th Floor Corporate Tower, Subang Square, Jalan Ss15/4G
Subang Jaya; Selangor; Postal Code: 47500

Contact Details: Purchase the Elogio Asia Pacific Sdn. Bhd. report to view the information.

Website: http://www.elogioasia.com/

Basic Information
Outstanding Shares:
Purchase the Elogio Asia Pacific Sdn. Bhd. report to view the information.
Registered Capital:
Purchase the Elogio Asia Pacific Sdn. Bhd. report to view the information.
Financial Auditors:
Purchase the Elogio Asia Pacific Sdn. Bhd. report to view the information.
Incorporation Date:
July 11, 2008
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Secretary
Ownership Details
Purchase this report to view the information.
51%
Purchase this report to view the information.
49%
Company Performance
Financial values in the chart are available after Elogio Asia Pacific Sdn. Bhd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
85.34%
Total operating revenue
85.34%
Operating profit (EBIT)
42.23%
EBITDA
34.45%
Net Profit (Loss) for the Period
37.04%
Total assets
109.73%
Total equity
54.59%
Operating Profit Margin (ROS)
-0.96%
Net Profit Margin
-0.86%
Return on Equity (ROE)
-4.53%
Debt to Equity Ratio
63.62%
Quick Ratio
0.04%
Cash Ratio
-0.04%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?